Manipulation of inhibin during the luteal-follicular phase transition of the primate menstrual cycle fails to affect FSH secretion

1994 ◽  
Vol 142 (1) ◽  
pp. 181-186 ◽  
Author(s):  
H M Fraser ◽  
C G Tsonis
Keyword(s):  
Phase Transition ◽  
Menstrual Cycle ◽  
Luteal Phase ◽  
Elevated Serum ◽  
Follicular Phase ◽  
Serum Concentrations ◽  
Late Luteal Phase ◽  
Early Follicular Phase ◽  
Negative Feedback Control

Abstract The pattern of inhibin concentrations in blood during the menstrual cycle in primates has suggested an endocrine role of inhibin in the negative feedback control of FSH secretion during the luteal phase. Conversely, the fall in inhibin during the late luteal phase may play a role in the rise in serum FSH during the luteal-follicular phase transition. This hypothesis was examined by determining the effects of manipulation of inhibin on FSH secretion in stumptailed macaques. During the mid-luteal phase the putative inhibin feedback was inhibited by i.v. administration of 20 ml of ovine antiserum to human recombinant inhibin in 4 macaques. FSH secretion was unaffected during the initial 24 h period post-treatment and the timing of the rise in FSH which occurred during the subsequent luteal-follicular phase transition was normal. To determine whether the elevated serum concentrations of FSH observed during the early follicular phase could be reduced by administration of inhibin, 5 cyclic macaques were treated with 200 μg of recombinant human inhibin i.v. Serum FSH concentrations were unaltered. These results suggest that inhibin does not play a major role in modulating FSH secretion during the luteal-follicular phase transition. Journal of Endocrinology (1994) 142, 181–186

Immunoneutralization and immunocytochemical localization of inhibin α subunit during the mid-luteal phase in the stump-tailed macaque

1992 ◽  
Vol 133 (3) ◽  
pp. 341-NP ◽  
Author(s):  
H. M. Fraser ◽  
K. B. Smith ◽  
S. F. Lunn ◽  
G. M. Cowen ◽  
K. Morris ◽  
...  
Keyword(s):  
Corpus Luteum ◽  
Luteal Phase ◽  
Treatment Cycle ◽  
Serum Concentrations ◽  
Serum Samples ◽  
Α Subunit ◽  
Late Luteal Phase ◽  
Early Follicular Phase

ABSTRACT The putative endocrine role of inhibin in the control of FSH secretion during the luteal phase in the primate was investigated by immunoneutralization. Antisera against the 1–23 amino acid sequence of the N-terminus of the human inhibin α subunit were raised in a ewe and three macaques. Antisera (10–20 ml) were administered to macaques on day 8/9 of the luteal phase and serum samples collected during the treatment cycle and post-treatment cycle for determination of FSH, oestradiol and progesterone. In addition, localization of inhibin within the macaque ovary at this stage of the luteal phase was investigated using the ovine antiserum. Intense immunostaining was localized within the granulosa-lutein cells of the corpus luteum with absence of staining in the thecalutein cells or other ovarian compartments. Administration of antisera was without significant effect on serum concentrations of FSH when compared with control animals, either during the first 24 h of detailed observation or for the following 10-day period of the late luteal phase and subsequent early follicular phase. These results provide further evidence that the corpus luteum is the major source of inhibin immunoreactivity during the primate menstrual cycle, but fail to support an endocrine role for inhibin in the suppression of FSH secretion. Journal of Endocrinology (1992) 133, 341–347

THE SEQUENCE OF PITUITARY RESPONSES TO SYNTHETIC LUTEINIZING HORMONE RELEASING HORMONE (LH-RH) THROUGHOUT THE NORMAL MENSTRUAL CYCLE

1975 ◽  
Vol 79 (4) ◽  
pp. 625-634 ◽  
Author(s):  
Elwyn M. Grimes ◽  
Irwin E. Thompson ◽  
Melvin L. Taymor
Keyword(s):  
Menstrual Cycle ◽  
Luteal Phase ◽  
Follicular Phase ◽  
Lh Surge ◽  
Luteinizing Hormone Releasing Hormone ◽  
Late Luteal Phase ◽  
Normal Menstrual Cycle ◽  
Early Follicular Phase ◽  
Lh Rh ◽  
Late Follicular Phase

ABSTRACT Thirty-one ovulatory women between 20 and 33 years of age were given 150 μg of synthetic LH-RH during different phases of the menstrual cycle. Five patients were studied during the early follicular phase (days 4–7); 10 patients during the late follicular phase (days 9–12); 6 patients during the "LH Surge"; 5 patients during the early luteal phase (days 14–16); 3 patients during mid-luteal phase (days 17–21); and 2 patients during late luteal phase (days 22–27). Oestrogen, progesterone, FSH and LH levels were determined from 30 min prior to LH-RH administration to 90 min thereafter in all cases. LH response to LH-RH increased progressively during the follicular phase. Enhanced pituitary responsiveness to LH-RH occurred at mid-cycle for both LH and FSH and maximum LH responses occurred during the "LH Surge" and early luteal phase. LH responses during the mid and late luteal phases were similar to late follicular phase responses. There were no significant differences between FSH responses during the early follicular, late follicular, mid-luteal and late luteal phases. Maximum pituitary responsiveness appears to occur in a gonadal steroid milieu of high oestrogen levels in association with rising but low progesterone levels. Progesterone or a crucial oestrogen: progesterone ratio may in fact potentiate pituitary release of LH during the early stages of corpus luteum formation. Pituitary responsiveness to LH-RH correlates positively with basal LH and oestrogen levels during the menstrual cycle and with the oestrogen:progesterone ratio during the luteal phase.

The Role of Transient Hyperprolactinaemia in the Short Luteal Phase

1980 ◽  
Vol 25 (4) ◽  
pp. S75-S81
Author(s):  
J. R. T. Coutts ◽  
R. Fleming ◽  
M. C. Macnaughton
Keyword(s):  
Luteal Phase ◽  
Follicular Phase ◽  
Cycle Period ◽  
Plasma Analysis ◽  
Steroid Secretion ◽  
Menstrual Cycles ◽  
Infertile Women ◽  
Late Luteal Phase ◽  
Early Follicular Phase

Daily plasma analysis of complete menstrual cycles from infertile women (n = 32) revealed transient hyperprolactinaemia in a significant number in comparison with normally cycling women. The prolactin elevations occurred for variable durations at different stages of the cycle. Transient hyperprolactinaemia occurring at mid-cycle was associated with reduced late luteal phase steroid levels and short luteal phases. When the prolactin elevations occurred at other times they were unrelated to ovarian steroid levels. Treatment of patients with short luteal phases with bromocriptine (2.5 mg/day) normalised prolactin levels but also reduced gonadotrophins. The net result of these changes was a normalisation of the length of the luteal phase which was now deficient in steroid secretion. To alleviate these problems the treatments proposed for the short luteal phase are either bromocriptine (2.5 mg/day) for 7 days over the mid-cycle period only or bromocriptine for 7 days at mid-cycle in conjunction with a follicular stimulant in the early follicular phase.

Altered Serotonergic Activity in Women with Dysphoric Premenstrual Syndromes

1993 ◽  
Vol 23 (1) ◽  
pp. 1-27 ◽  
Author(s):  
Uriel Halbreich ◽  
Henry Tworek
Keyword(s):  
Treatment Outcome ◽  
Menstrual Cycle ◽  
Luteal Phase ◽  
Symptomatic Treatment ◽  
Gonadal Hormones ◽  
Interactive System ◽  
Library Search ◽  
Serotonergic Activity ◽  
Late Luteal Phase

Objective: Dysphoric Premenstrual Syndromes (PMS) are quite prevalent and in some women they are severe enough to warrant treatment. Their pathophysiology is still unknown, despite increased interest and research. Here we review the possible role of serotonin in the multidimensional interactive pathophysiology of PMS. Method: Over 170 articles are reviewed. An extensive library search has been conducted and articles are included because of their relevance to: 1) the phenomenology of PMS; 2) the putative association of serotonergic (5-HT) activity with syndromes that occur premenstrually; 3) changes in 5-HT activity along the menstrual cycle, especially the late luteal phase; 4) influence of gonadal hormones on serotonergic functions; 5) endocrine strategies for assessment of 5-HT abnormalities; and 6) treatment studies of PMS with serotonergic agonists. Results and Conclusions: The data presented here suggest that post-synaptic serotonergic responsivity might be altered during the late-luteal-premenstrual phase of the menstrual cycle. Some serotonergic functions of women with PMS might be altered during the entire cycle and be associated with a vulnerability trait. It is hypothesized that gonadal hormones might cause changes in levels of activity of 5-HT systems as part of a multidimensional interactive system. Strategies to evaluate 5-HT activities in the context of the menstrual cycle are discussed—leading to the conclusion that the most promising approach is active stimulation with specific post-synaptic serotonin agonists. Treatment outcome studies of some imperfect compounds that are currently applied as a symptomatic treatment of PMS support the notion that 5-HT is involved in the pathophysiology of these syndromes.

Response to flumazenil in the late luteal phase and follicular phase of the menstrual cycle in healthy control females

2004 ◽  
Vol 172 (3) ◽  
pp. 248-254 ◽  
Author(s):  
Emily C. Bell ◽  
Glen B. Baker ◽  
Christina Poag ◽  
Francois Bellavance ◽  
Janisse Khudabux ◽  
...  
Keyword(s):  
Menstrual Cycle ◽  
Luteal Phase ◽  
Follicular Phase ◽  
Late Luteal Phase ◽  
Healthy Control

scholarly journals Parasympathetic Nerve Function Status During Different Phases Of Menstrual Cycle In Healthy Young Women

1970 ◽  
Vol 6 (2) ◽  
pp. 100-107 ◽  
Author(s):  
Rama Choudhury ◽  
Nasim Jahan ◽  
Nayma Sultana ◽  
Rezina Akter ◽  
Ayesha Akhter Khanum
Keyword(s):  
Menstrual Cycle ◽  
Luteal Phase ◽  
Follicular Phase ◽  
Parasympathetic Activity ◽  
Autonomic Nerve ◽  
Nerve Function ◽  
Deep Breathing ◽  
Parasympathetic Nerve ◽  
Autonomic Nerve Function ◽  
Late Luteal Phase

Background: Autonomic nerve function status may be changed during follicular and late luteal phases of menstrual cycle due to fluctuations of serum estrogen and progesterone levels. This alteration in autonomic nerve functions may affect cardiovagal control and usually associated with decreased parasympathetic activity in late luteal phase. Objective: To observe the parasympathetic nerve function status during follicular and late luteal phases of menstrual cycle and also their relationships with serum estrogen and progesterone levels in healthy young women. Methods: This cross-sectional study was carried out in the Department of Physiology, Sir Salimullah Medical College (SSMC), Dhaka from 1st January 2009 to 31st December 2009. A total number of thirty (30) apparently healthy unmarried women age ranged from 20-25 years were studied in both follicular (phase A, control) and late luteal (phase B, study) phases of menstrual cycle. Simple autonomic nerve function tests like heart rate (HR) response to valsalva maneuver (valsalva ratio), HR response to deep breathing, HR response to standing (30th:15th ratio) were done to assess parasympathetic activity and serum estrogen and progesterone levels were also measured by AxSYM method. All these tests were performed in both follicular and late luteal phases of menstrual cycle of the same subject. Data were analysed by paired student’s ‘t’ test and Pearson’s correlation coefficient test as applicable. Results: Mean values of both HR response to valsalva ratio and HR response to standing (30th:15 th ) were non-significantly decreased but HR response to deep breathing was significantly (p<0.05) decreased in late luteal phase than those of follicular phase. Conclusion: From this study it can be concluded that parasympathetic activity is decreased in late luteal phase of menstrual cycle. DOI: http://dx.doi.org/10.3329/jbsp.v6i2.9759 JBSP 2011 6(2): 100-107

scholarly journals Menstrual phase-dependent differences in neurobehavioral performance: the role of temperature and the progesterone/estradiol ratio

SLEEP ◽  
2019 ◽  
Vol 43 (2) ◽  
Author(s):  
Leilah K Grant ◽  
Joshua J Gooley ◽  
Melissa A St Hilaire ◽  
Shantha M W Rajaratnam ◽  
George C Brainard ◽  
...  
Keyword(s):  
Menstrual Cycle ◽  
Cognitive Performance ◽  
Sex Hormones ◽  
Luteal Phase ◽  
Light Exposure ◽  
Sleep Loss ◽  
Follicular Phase ◽  
Menstrual Phase ◽  
Nighttime Light

Abstract Study objectives Women in the luteal phase of the menstrual cycle exhibit better cognitive performance overnight than women in the follicular phase, although the mechanism is unknown. Given the link between core body temperature (CBT) and performance, one potential mechanism is the thermoregulatory role of progesterone (P4), estradiol (E2), and their ratio (P4/E2), which change across the menstrual cycle. We examined the role of P4/E2 in modulating performance during extended wake in premenopausal women. Additionally, we compared the acute effects of nighttime light exposure on performance, CBT, and hormones between the menstrual phases. Methods Participants were studied during a 50 h constant routine and a 6.5 h monochromatic nighttime light exposure. Participants were 16 healthy, naturally cycling women (eight follicular; eight luteal). Outcome measures included reaction time, attentional failures, self-reported sleepiness, CBT, melatonin, P4, and E2. Results As compared to women in the luteal phase, women in the follicular phase exhibited worse performance overnight. CBT was significantly associated with performance, P4, and P4/E2 but not with other sex hormones. Sex hormones were not directly related to performance. Light exposure that suppressed melatonin improved performance in the follicular phase (n = 4 per group) to levels observed during the luteal phase and increased CBT but without concomitant changes in P4/E2. Conclusions Our results underscore the importance of considering menstrual phase when assessing cognitive performance during sleep loss in women and indicate that these changes are driven predominantly by CBT. Furthermore, this study shows that vulnerability to sleep loss during the follicular phase may be resolved by exposure to light.

scholarly journals The menstrual cycle affects recognition of emotional expressions: an event-related potential study

F1000Research ◽  
2017 ◽  
Vol 6 ◽  
pp. 853 ◽  
Author(s):  
Madoka Yamazaki ◽  
Kyoko Tamura
Keyword(s):  
Menstrual Cycle ◽  
Facial Expressions ◽  
Cognitive Processing ◽  
Luteal Phase ◽  
Follicular Phase ◽  
Event Related Potential ◽  
Reproductive Age ◽  
Cycle Phase ◽  
Late Luteal Phase ◽  
The Relationship

Background: Several studies have investigated the relationship between behavioral changes and the menstrual cycle in female subjects at a reproductive age. The present study investigated the relationship between the menstrual cycle and emotional face recognition by measuring the N170 component of ERPs. Methods: We measured N170 of twelve women in both follicular phase and late luteal phase who were presented with human facial expressions as stimuli (happy and angry). Results: In the follicular phase, participants showed a significantly larger response to happy male facial expressions. In the late luteal phase, participants had longer reaction times to all emotional stimuli, and a significantly reduced response to happy faces, especially happy male facial expressions (P<0.001). Conclusions: Our findings suggest that the menstrual cycle modulates early visual cognitive processing, and highlight the importance of considering the menstrual cycle phase in studies that investigate emotion and cognition.

Cortisol, 17α-OH-progesterone and androgen responses to a standardized ACTH-stimulation in different stages of the normal menstrual cycle

1982 ◽  
Vol 100 (3) ◽  
pp. 427-433 ◽  
Author(s):  
N. Kruyt ◽  
R. Rolland
Keyword(s):  
Menstrual Cycle ◽  
Luteal Phase ◽  
Follicular Phase ◽  
Adrenal Hyperplasia ◽  
Acth Stimulation Test ◽  
Normal Range ◽  
Acth Stimulation ◽  
Normal Menstrual Cycle ◽  
Early Follicular Phase ◽  
Three Stages

Abstract. The release of cortisol, 17α-OH-progesterone, androstenedione and testosterone during a standardized ACTH-stimulation test was investigated in three different stages of the normal menstrual cycle, to conclude if there is any stage dependency on the release of these hormones. No statistically significant differences were observed between the three stages concerning cortisol and testosterone increase. The increase of androstenedione in the pre-ovulatory stage was significantly higher than that seen during the early follicular phase of the cycle. The increase of 17α-OH-progesterone in the luteal phase was significantly less than that of both the early and late follicular stages of the cycle. Progesterone levels showed a small, but significant increase after ACTH-stimulation, in both the early and late stage of the follicular phase. However, the levels remained within the normal range of the follicular phase. In the luteal phase no increase was seen after ACTH-stimulation. Oestradtiol-17β levels did not change at all after ACTH-stimulation. The stage dependency of androstenedione and 17α-OH-progesterone is discussed. The described stage-dependency different increase of 17α-OH-progesterone release can be of importance when the results of ACTH-tests are evaluated to detect carriers of congenital adrenal hyperplasia.

Sign in / Sign up

Export Citation Format

Share Document